Medical and Dental Consultantsí Association of Nigeria
Home - About us - Editorial board - Search - Ahead of print - Current issue - Archives - Submit article - Instructions - Subscribe - Advertise - Contacts - Login 
  Users Online: 1869   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
 
REVIEW ARTICLE
Year : 2015  |  Volume : 18  |  Issue : 5  |  Page : 577-583

The association between endometriosis and survival outcomes of ovarian cancer: Evidence-based on a meta-analysis


1 Department of Obstetrics and Gynaecology, Chengde Central Hospital, Hebei 067000, China
2 Department of Neurology, Chengde Central Hospital, Hebei 067000, China
3 Department of Reproductive Medicine, Chengde Central Hospital, Hebei 067000, China
4 Computer Techniques and Information Management Center, Chengde Central Hospital, Hebei 067000, China

Correspondence Address:
B Yang
Department of Obstetrics and Gynaecology, Chengde Central Hospital, No. 22, North Road, West Street, Shuangqiao District, Chengde, Hebei 067000
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1119-3077.158941

Rights and Permissions

Background: Although it is generally recognized that endometriosis was significantly associated with higher risk of ovarian cancer, the association between endometriosis and the cancer survival outcomes is still not clear. This meta-analysis aims to pool previous studies and to make an update estimate. Methods: Relevant studies were searched among PubMed, Medline and Embase. Hazard ratio (HR) and the corresponding 95% confidence intervals (CI) of progression-free survival (PFS) and overall survival (OS) were pooled with generic inverse variance method. The proportion of the low stage and grade tumors (stage: Stage I and II among total; grade: Grade I among total) in endometriosis-associated ovarian cancer (EAOC) group and in non-EAOC group were assessed with odd ratio and the corresponding 95% CI. Results: Endometriosis-associated ovarian cancer were significantly associated with higher rate of OS in crude analysis (HR: 0.74, 95% CI: 0.63-0.87, P = 0.0003). However, in most of the studies included, the OS benefit was not significant under multivariable survival analysis. EAOC patients generally had early-stage, low histological grade tumors and younger age compared with non-EAOC patients. No difference was observed in PFS between the two groups. Conclusion: The OS benefits associated with endometriosis might be closely related to higher prevalence of patients diagnosed at early-stage and greater chance of receiving optimal cytoreductive surgery or chemotherapy. Endometriosis should not be viewed as an independent prognostic factor of ovarian cancer.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2506    
    Printed47    
    Emailed0    
    PDF Downloaded506    
    Comments [Add]    
    Cited by others 2    

Recommend this journal